By analyzing the tumor environment of diffuse large B-cell lymphoma (DLBCL), researchers from The University of Texas MD Anderson Cancer Center have identified seven distinct cellular microenvironments, providing a framework to develop therapies that will engage a patient’s immune system to attack cancer cells. Each microenvironment showed a different mix of cells and its own pattern of communication between tumor B-cells and immune cells.
This article was originally published on MedicalXpress.com
